Loading...
XJPX4967
Market cap2.81bUSD
Dec 25, Last price  
5,947.00JPY
1D
-0.70%
1Q
4.06%
Jan 2017
18.94%
Name

Kobayashi Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XJPX:4967 chart
P/E
21.74
P/S
2.55
EPS
273.58
Div Yield, %
1.63%
Shrs. gr., 5y
-0.83%
Rev. gr., 5y
0.70%
Revenues
173.46b
+4.33%
216,052,000,000247,335,000,000257,502,000,000228,133,000,000125,544,000,000129,082,000,000130,528,000,000131,166,000,000121,532,000,000127,293,000,000128,344,000,000137,211,000,000160,067,599,830156,761,000,000167,479,000,000168,052,000,000150,514,000,000155,252,000,000166,258,000,000173,455,000,000
Net income
20.34b
+1.58%
6,730,000,0007,474,000,0008,297,000,0008,504,000,0008,853,000,0009,249,000,0009,335,000,00011,726,000,00012,176,000,00012,307,000,00012,448,000,00013,466,000,00019,094,618,93015,863,000,00018,023,000,00019,139,000,00019,205,000,00019,715,000,00020,022,000,00020,338,000,000
CFO
18.36b
-42.47%
8,364,000,00013,159,000,0008,833,000,00012,192,000,00012,849,000,00015,319,000,00013,168,000,00017,250,000,0009,242,000,00013,513,000,00015,445,000,00014,329,000,00016,097,000,00022,350,000,00020,007,000,00020,089,000,00023,986,000,00022,419,000,00031,914,000,00018,360,000,000
Dividend
Dec 27, 202459 JPY/sh
Earnings
Feb 07, 2025

Profile

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, household products, skincare, and body warmers. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eyebon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
URL
https://www.kobayashi.co.jp/
IPO date
Apr 20, 1999
Employees
3,495
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122016‑032015‑03
Income
Revenues
173,455,000
4.33%
166,258,000
7.09%
155,252,000
3.15%
Cost of revenue
143,694,000
113,862,000
105,790,000
Unusual Expense (Income)
NOPBT
29,761,000
52,396,000
49,462,000
NOPBT Margin
17.16%
31.51%
31.86%
Operating Taxes
7,221,000
7,927,000
7,920,000
Tax Rate
24.26%
15.13%
16.01%
NOPAT
22,540,000
44,469,000
41,542,000
Net income
20,338,000
1.58%
20,022,000
1.56%
19,715,000
2.66%
Dividends
(7,223,000)
(6,509,000)
(6,251,000)
Dividend yield
1.40%
0.93%
0.89%
Proceeds from repurchase of equity
(12,000,000)
(14,055,000)
(3,931,000)
BB yield
2.33%
2.02%
0.56%
Debt
Debt current
379,000
261,000
170,000
Long-term debt
1,595,000
1,323,000
1,089,000
Deferred revenue
2,019,000
Other long-term liabilities
3,344,000
4,278,000
2,209,000
Net debt
(113,796,000)
(123,158,000)
(123,231,000)
Cash flow
Cash from operating activities
18,360,000
31,914,000
22,419,000
CAPEX
(13,569,000)
(16,229,000)
(4,185,000)
Cash from investing activities
(19,576,000)
(14,312,000)
7,991,000
Cash from financing activities
(19,463,000)
(20,759,000)
(10,377,000)
FCF
(358,000)
37,714,000
37,492,000
Balance
Cash
79,836,000
104,533,000
109,046,000
Long term investments
35,934,000
20,209,000
15,444,000
Excess cash
107,097,250
116,429,100
116,727,400
Stockholders' equity
229,058,000
211,859,000
215,069,000
Invested Capital
102,049,750
81,631,900
79,254,600
ROIC
24.54%
55.28%
53.48%
ROCE
14.06%
26.28%
25.04%
EV
Common stock shares outstanding
75,842
77,132
78,125
Price
6,790.00
-24.81%
9,030.00
-0.11%
9,040.00
-28.31%
Market cap
514,967,180
-26.06%
696,501,960
-1.38%
706,250,000
-28.35%
EV
401,171,180
573,343,960
583,019,000
EBITDA
35,818,000
57,754,000
54,297,000
EV/EBITDA
11.20
9.93
10.74
Interest
29,000
18,000
18,000
Interest/NOPBT
0.10%
0.03%
0.04%